Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 0.175M
March 31, 2026 -1.111M
December 31, 2025 5.713M
September 30, 2025 6.387M
June 30, 2025 -0.367M
March 31, 2025 11.77M
December 31, 2024 -2.863M
September 30, 2024 1.533M
June 30, 2024 -27.09M
March 31, 2024 -28.56M
December 31, 2023 1.104M
September 30, 2023 -1.107M
June 30, 2023 -1.571M
March 31, 2023 -3.284M
December 31, 2022 0.033M
September 30, 2022 -1.309M
June 30, 2022 -2.22M
March 31, 2022 -10.08M
December 31, 2021 -5.48M
September 30, 2021 -11.00M
June 30, 2021 -2.412M
March 31, 2021 -2.533M
December 31, 2020 -2.488M
September 30, 2020 -0.77M
June 30, 2020 -1.729M
Date Value
March 31, 2020 -0.761M
December 31, 2019 -0.414M
September 30, 2019 -1.994M
June 30, 2019 -0.812M
March 31, 2019 -0.445M
December 31, 2018 -0.693M
September 30, 2018 -0.601M
June 30, 2018 -1.456M
March 31, 2018 -0.016M
December 31, 2017 -0.245M
September 30, 2017 0.014M
June 30, 2017 -0.441M
March 31, 2017 -0.236M
December 31, 2016 -0.094M
September 30, 2016 -0.301M
June 30, 2016 -0.209M
March 31, 2016 -0.238M
December 31, 2015 -0.792M
September 30, 2015 -0.155M
June 30, 2015 -0.253M
March 31, 2015 -0.057M
December 31, 2014 -0.033M
September 30, 2014 0.10M
June 30, 2014 0.974M
March 31, 2014 3.606M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Lifecore Biomedical, Inc. -0.513M
Quanterix Corp. 13.66M
Frontage Holdings Corp. --
Repligen Corp. -2.089M
Bio-Techne Corp. -7.057M